Medibest Pharma Private Limited
About Medibest Pharma Private Limited
Data last updated:
Medibest Pharma Private Limited is a private limited company based in Hosur, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 July 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24231TZ1985PTC003995. Its GSTIN is 29AABCM4458N1ZW (Karnataka). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹5.25 Cr and a paid-up capital of ₹4.41 Cr. It is led by directors including Puthucode Venkateswaran (Managing Director) and Shanthi Sankar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No 31 SIDCO Industrial Estate, Hosur, Tamil Nadu, India – 635126.
As per the financials filed for FY 2024, the company reported a revenue of ₹43.84 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net profit of ₹27.62 Cr (net margin 63%) and EBITDA of ₹28.83 Cr (EBITDA margin 65.8%). Revenue has grown at a compounded annual rate (CAGR) of 96% over three years and 49% over five years.
As per MCA filings, the company has open charges of ₹12.44 Cr and satisfied charges of ₹5.97 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medibest Pharma Private Limited's registered office is in Hosur, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo 31 SIDCO Industrial Estate, Hosur, Tamil Nadu, India – 635126
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medibest Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medibest Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medibest Pharma Private Limited, buy the company report.
Financials of Medibest Pharma Private Limited
FY 2024 filings availableMedibest Pharma Private Limited reported revenue of ₹43.84 Cr (up 65% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years, including 65% growth in the latest year. EBITDA rose 895% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹43.84 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.62 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 65.8% | ||||
| Net Profit Margin | 63% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medibest Pharma Private Limited, buy the company report.
Board of directors of Medibest Pharma Private Limited
Medibest Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Puthucode Venkateswaran | Managing Director | 31 Jul 1985 | 41 Years 2 Months | Current |
| Shanthi Sankar | Director | 24 Nov 2016 | 9 Years 11 Months | Current |
| Puthukode Venkateswaran Vigneshwar | Director | 23 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Medibest Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Affine Formulations Limited | ₹44.05 Cr (FY 2022) | 4.0% | Indore, Madhya Pradesh, India | |||
| Quality Pharma Products Private Limited | ₹43.95 Cr (FY 2025) | 22.0% | Assam, India | |||
| Varahi Pharma Private Limited | ₹43.85 Cr (FY 2021) | 46.0% | Hyderabad, Telangana, India | |||
| Medibest Pharma Private Limitedthis company | ₹43.84 Cr (FY 2024) | ₹27.62 Cr | 63% | 65.0% | Hosur, Tamil Nadu, India | |
| Tristar Formulations Private Limited | ₹43.68 Cr (FY 2025) | -25.0% | Puducherry, India | |||
| Dhara Lifescience Private Limited | ₹43.49 Cr (FY 2024) | -14.0% | Ahmedabad, Gujarat, India | |||
| Orchev Pharma Pvt Ltd | ₹43.44 Cr (FY 2025) | 14.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Medibest Pharma Private Limited, buy the company report.
Auditor
Medibest Pharma Private Limited is audited by Mani Srinivasan & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mani Srinivasan & Associates | FY 2024 | 022018S |
Shareholding
The shareholding of Medibest Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medibest Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Feb 2025 | 101064353 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 27 Dec 2024 | 101030567 | Sidbi | ₹1.85 Cr | Open | |
| 30 Sep 2022 | 100620608 | City Union Bank Limited | ₹10.22 Cr | Open | |
| 14 Jul 2021 | 100466456 | Hdfc Bank Limited | ₹7.07 Lakh | Open | |
| 09 Jul 2008 | 10109938 | Tamilnadu Industrial Investment Corporation Limited | ₹3.52 Cr | Satisfied |
To see the full charge records of Medibest Pharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Medibest Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, UTTARA KANNADA, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instance of Asst. Drugs Controller, Uttar Kannada Circle, Karwar | Disposed |
To see the full case history of Medibest Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Medibest Pharma Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Deepam Poly Packs Private Limited | |||
| Nice Prints | |||
| an individual supplier | |||
| Classic Welding Products Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Medibest Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Medibest Pharma has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCM4458N1ZW | Karnataka | Active | 01 Jul 2017 |
| 32AABCM4458N1Z9 | Kerala | Active | 01 Jul 2017 |
| 33AABCM4458N1Z7 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medibest Pharma Private Limited, buy the company report.
Recent activity
Medibest Pharma Private Limited has 8 board changes on record since 1985: 3 appointments and 5 cessations. The latest: Kasi Viswanathan Krishnan ceased to be Whole-Time Director on 07 Mar 2022.
16 earlier events are in the company report.
Frequently asked questions
Medibest Pharma is an active private limited company based in Hosur, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 July 1985 (41+ years old) and is registered under CIN U24231TZ1985PTC003995.
Medibest Pharma has 3 current directors:
- Puthucode Venkateswaran - Managing Director
- Shanthi Sankar - Director
- Puthukode Venkateswaran Vigneshwar - Director
The latest financial statements of Medibest Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Medibest Pharma is 29AABCM4458N1ZW, registered in Karnataka. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 32AABCM4458N1Z9 (Kerala), 33AABCM4458N1Z7 (Tamil Nadu).
The CIN (Corporate Identification Number) of Medibest Pharma is U24231TZ1985PTC003995. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medibest Pharma has 1 court case on record: 1 filed against it.
Medibest Pharma was incorporated on 31 July 1985, making it 41+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Medibest Pharma by revenue are Affine Formulations Limited, Quality Pharma Products Private Limited, Varahi Pharma Private Limited, Tristar Formulations Private Limited, Dhara Lifescience Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kasi Viswanathan Krishnan ceased to be Whole-Time Director on 07 Mar 2022. Puddukadu Venkateswaran Kasiviswanathan ceased to be Whole-Time Director on 10 Jan 2019. Puthokode Venkateswaran Ramasway ceased to be Whole-Time Director on 10 Jan 2019. Medibest Pharma has 8 board changes on record in total.
Medibest Pharma has 5 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 5 micro and small suppliers. The latest return was filed on 23 Apr 2022.
The registered office of Medibest Pharma is at No 31 SIDCO Industrial Estate, Hosur, Tamil Nadu, India – 635126.
Medibest Pharma operates in the pharma industry, in the drug formulation and development segment.